PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 76 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $283,000 | +3.7% | 38,428 | -4.5% | 0.00% | 0.0% |
Q2 2017 | $273,000 | -30.9% | 40,235 | -3.8% | 0.00% | -50.0% |
Q1 2017 | $395,000 | +7.6% | 41,813 | -1.6% | 0.00% | 0.0% |
Q4 2016 | $367,000 | +31.1% | 42,505 | -3.8% | 0.00% | +100.0% |
Q3 2016 | $280,000 | +49.7% | 44,204 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $187,000 | -3.1% | 44,204 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $193,000 | -32.0% | 44,204 | -4.7% | 0.00% | 0.0% |
Q4 2015 | $284,000 | +9.7% | 46,383 | +2.3% | 0.00% | 0.0% |
Q3 2015 | $259,000 | -23.4% | 45,320 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $338,000 | +11.2% | 45,320 | -10.9% | 0.00% | 0.0% |
Q1 2015 | $304,000 | -24.9% | 50,889 | -4.9% | 0.00% | -50.0% |
Q4 2014 | $405,000 | +43.6% | 53,539 | -1.4% | 0.00% | +100.0% |
Q3 2014 | $282,000 | +20.5% | 54,314 | +0.2% | 0.00% | 0.0% |
Q2 2014 | $234,000 | +8.8% | 54,184 | +3.3% | 0.00% | 0.0% |
Q1 2014 | $215,000 | -13.0% | 52,462 | +13.4% | 0.00% | 0.0% |
Q4 2013 | $247,000 | -32.1% | 46,261 | -36.0% | 0.00% | -50.0% |
Q3 2013 | $364,000 | +33.3% | 72,294 | +18.1% | 0.00% | +100.0% |
Q2 2013 | $273,000 | – | 61,218 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |